Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 14-02-2024
The Turnover for the quarter ended December 2023 of Rs. 6253.00 millions increase by 51.40% from Rs. 4130.00 millions.Net Profit for the quarter ended December 2023 zoomed to 414.75% from Rs. 373.00 millions to Rs. 1920.00  millions.The company reported a good operating profit of 2678.00 millions compared to 861.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 6253.00 4130.00 51.40 26041.00 15698.00 65.89 23510.00 17678.00 32.99
Other Income 295.00 186.00 58.60 688.00 680.00 1.18 855.00 946.00 -9.62
PBIDT 2678.00 861.00 211.03 12531.00 5850.00 114.21 9302.00 3076.00 202.41
Interest 38.00 30.00 26.67 100.00 74.00 35.14 86.00 133.00 -35.34
PBDT 2640.00 831.00 217.69 12431.00 5776.00 115.22 9216.00 2943.00 213.15
Depreciation 404.00 381.00 6.04 1203.00 1133.00 6.18 1509.00 1384.00 9.03
PBT 2236.00 450.00 396.89 11228.00 4643.00 141.83 7707.00 1559.00 394.36
TAX 316.00 77.00 310.39 1653.00 813.00 103.32 1336.00 168.00 695.24
Deferred Tax -105.00 -3.00 3400.00 -359.00 -19.00 1789.47 5.00 -157.00 -103.18
PAT 1920.00 373.00 414.75 9575.00 3830.00 150.00 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 42.83 20.85 105.43 48.12 37.27 29.13 39.57 17.40 127.39